Nrx Pharmaceuticals Inc (NRXP) Stock Price, Quote & News

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100,...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 254 6134

Website: www.nrxpharma.com

Address:

1201 N. Market Street, Suite 111, Wilmington, United States

fuctonfauci Aug. 12 at 5:35 PM

$NRXP It looks like value is once again being created for loyal long-term shareholders. "not June 2026, June 2027" ...

0 · Reply

MysteriousMoney Aug. 12 at 5:16 PM

Ticker NAMI ran +300% the other day and is setting off again! NAMI is another china squeezer with only 400 watchers on Stocktwits and barely on anyones radar. If NAMI can break its high of week 10$, it could trigger a massive china squeeze. Took a large stake myself, betting on a big breakout on NAMI. Watch it. $NRXP $MRVL $AXSM z\\

0 · Reply

RobZEBRA Aug. 12 at 3:50 PM

$NRXP the charts?

0 · Reply

Ketasniffer Aug. 12 at 3:23 PM

$NRXP when is earnings call?

3 · Reply

dcrmia Aug. 12 at 3:22 PM

$NRXP

0 · Reply

alwaysWinVlmr Aug. 12 at 3:08 PM

$NRXP

0 · Reply

Bigtuna42 Aug. 12 at 1:42 PM

$NRXP I could be wrong and again I have been following and invested in this company since NOV2024. Seems like a lot of people continue to have negative comments. If you all are so unhappy why are you still invested in the company? Why not just get out and get into something that you’re more comfortable with?

3 · Reply

fuctonfauci Aug. 12 at 12:20 PM

$NRXP Javitt also said NRx had been prepared to submit a new drug application, or NDA, for a separate product in June but focused on resolving the vial issue because the same packaging applies to both products. He said the company now plans to return attention to the NDA and continues to expect it to be addressed within roughly 12 months from June.

2 · Reply